Yngvild Nuvin Blaker

Image of Yngvild Nuvin Blaker
Norwegian version of this page
Username
Visiting address OUS Radiumhospitalet Ullernchausseen 70 0372 Oslo
Postal address OUS, Rikshospitalet Postboks 4950 Nydalen 0424 Oslo

Publications

  • Jakobsen, Lasse Hjort; Ellin, Fredrik; Smeland, Knut Bjøro; Wästerlid, Tove; Christensen, Jacob Haaber; Jørgensen, Judit Mészáros; Josefsson, Pär Lars; Øvlisen, Andreas K.; Holte, Harald; Blaker, Yngvild Nuvin; Grauslund, Jacob Handlos; Bjørn, Jon; Molin, Daniel; Lagerlöf, Ingemar; Smedby, Karin Ekström; Colvin, Katherine; Thanarajasingam, Gita; Maurer, Matthew J.; Habermann, Thomas Matthew; Song, Kevin W.; Song, Katie Y.; Gerrie, Alina S.; Cheah, Chan Yoon & El-Galaly, Tarec Christoffer (2020). Minimal relapse risk and early normalization of survival for patients with Burkitt lymphoma treated with intensive immunochemotherapy: an international study of 264 real‐world patients. British Journal of Haematology.  ISSN 0007-1048.  189(4), s 661- 671 . doi: 10.1111/bjh.16425 Full text in Research Archive.
  • Wise, Jillian; Nakken, Sigve; Steen, Chloe Beate; Vodak, Daniel; Trøen, Gunhild; Johannessen, Bjarne; Lingjærde, Ole Christian; Hilden, Vera Irene; Blaker, Yngvild Nuvin; Bai, Baoyan; Aasheim, Lars Birger; Pasanen, Annika; Lorenz, Susanne; Sveen, Anita; Lothe, Ragnhild A; Myklebost, Ola; Leppä, Sirpa; Meza, Leonardo Zepeda; Beiske, Klaus; Lawrence, Michael S.; Hovig, Eivind; Myklebust, June Helen; Smeland, Erlend B. & Holte, Harald (2020). Mutational dynamics and immune evasion in diffuse large B-cell lymphoma explored in a relapse-enriched patient series. Blood Advances.  ISSN 2473-9529.  4(9), s 1859- 1866 . doi: 10.1182/bloodadvances.2019001325 Show summary
  • Josefsson, Sarah Elisabet; Beiske, Klaus; Blaker, Yngvild Nuvin; Førsund, Mette S; Holte, Harald; Østenstad, Bjørn; Kimby, Eva; Köksal, Hakan; Wälchli, Sébastien; Bai, Baoyan; Smeland, Erlend B; Levy, Ronald; Kolstad, Arne; Huse, Kanutte & Myklebust, June (2019). TIGIT and PD-1 mark intratumoral T cells with reduced effector function in B-cell non-Hodgkin lymphoma. Cancer immunology research.  ISSN 2326-6066.  7(3), s 355- 362 . doi: 10.1158/2326-6066.CIR-18-0351 Full text in Research Archive.
  • Köksal, Hakan; Dillard, Pierre; Josefsson, Sarah Elisabet; Maggadottir, Solrun Melkorka; Pollmann, Sylvie Mireille; Fåne, Anne; Blaker, Yngvild Nuvin; Beiske, Klaus; Huse, Kanutte; Kolstad, Arne; Holte, Harald; Kvalheim, Gunnar; Smeland, Erlend B; Myklebust, June Helen; Inderberg, Else Marit & Wälchli, Sébastien (2019). Preclinical development of CD37CAR T-cell therapy for treatment of B-cell lymphoma. Blood Advances.  ISSN 2473-9529.  3(8), s 1230- 1243 . doi: 10.1182/bloodadvances.2018029678 Full text in Research Archive.
  • Federico, Massimo; Caballero Barrigón, María Dolores; Marcheselli, Luigi; Tarantino, Vittoria; Manni, Martina; Sarkozy, Clementine; Alonso-Álvarez, Sara; Wondergem, Marielle; Cartron, Guillaume; Lopez-Guillermo, Armando; Issa, Djamila; Morschhauser, Franck; Alcoceba, Miguel; Kimby, Eva; Rusconi, Chiara; Chamuleau, Martine; Holte, Harald; Lockmer, Sandra; Montoto, Silvia; Gomes da Silva, Maria; Aurer, Igor; Zucca, Emanuele; Paszkiewicz-Kozik, Ewa; Minoia, Carla; Skrypets, Tetiana; Blaker, Yngvild Nuvin; Salles, Gilles & Coiffier, Bertrand (2018). Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysis. The Lancet Haematology.  ISSN 2352-3026.  5(8), s e359- e367 . doi: 10.1016/S2352-3026(18)30090-5
  • Holte, Harald; Beiske, Klaus; Boyle, Merrill; Trøen, Gunhild; Blaker, Yngvild Nuvin; Myklebust, June; Kvaløy, Anne Sunniva; Rosenwald, Andreas; Lingjærde, Ole Christian; Rimsza, Lisa M.; Smeland, Erlend B; Scott, David W. & Kolstad, Arne (2018). The MCL35 gene expression proliferation assay predicts high-risk MCL patients in a Norwegian cohort of younger patients given intensive first line therapy. British Journal of Haematology.  ISSN 0007-1048.  s 1- 10 . doi: 10.1111/bjh.15518
  • Blaker, Yngvild Nuvin; Spetalen, Signe; Eide, Marianne Brodtkorb; Lingjærde, Ole Christian; Beiske, Klaus; Østenstad, Bjørn; Sander, Birgitta; Wahlin, Björn Engelbrekt; Melen, Christopher Michael; Myklebust, June; Holte, Harald; Delabie, Jan & Smeland, Erlend B (2016). The tumour microenvironment influences survival and time to transformation in follicular lymphoma in the rituximab era. British Journal of Haematology.  ISSN 0007-1048.  175(1), s 102- 114 . doi: 10.1111/bjh.14201
  • Blaker, Yngvild Nuvin; Brodtkorb, Marianne; Maddison, John; Hveem, Tarjei Sveinsgjerd; Nesheim, John Arne; Mohn, Hans Martin; Kolstad, Arne; Geisler, Christian H.; Liestøl, Knut; Smeland, Erlend B; Holte, Harald; Delabie, Jan & Danielsen, Håvard Emil (2015). Computerized image analysis of the Ki-67 proliferation index in mantle cell lymphoma. Histopathology.  ISSN 0309-0167.  67(1), s 62- 69 . doi: 10.1111/his.12624
  • Blaker, Yngvild Nuvin; Eide, Marianne Brodtkorb; Liestøl, Knut; Lauritzsen, Grete Fossum; Kolstad, Arne; Fosså, Alexander; Smeland, Erlend B & Holte, Harald (2014). High dose chemotherapy with autologous stem cell transplant for patients with transformed B-cell non-Hodgkin lymphoma in the rituximab era. Leukemia and Lymphoma.  ISSN 1042-8194.  55(10), s 2319- 2327 . doi: 10.3109/10428194.2013.871632

View all works in Cristin

  • Bai, Baoyan; Vodák, Daniel; Nakken, Sigve; Wise, Jillian; Blaker, Yngvild Nuvin; Lingjærde, Ole Christian; Brodtkorb, Marianne; Hilden, Vera Irene; Trøen, Gunhild; Lorenz, Susanne; Lawrence, Michael S.; Myklebost, Ola; Meza, Leonardo Zepeda; Beiske, Klaus; Hovig, Eivind; Smeland, Erlend B; Holte, Harald & Myklebust, June Helen (2019). Deep profiling of genetic aberrations and clonal evolution in follicular lymphoma. Blood.  ISSN 0006-4971.  134(1), s 20- 20 . doi: 10.1182/blood-2019-128403

View all works in Cristin

Published Sep. 14, 2017 10:54 AM - Last modified Nov. 2, 2020 1:45 PM